Noom Appoints Rachel Mahoney as Chief Brand Officer
September 17, 2024 08:02 ET
|
Noom Inc
Noom is pleased to announce the appointment of Rachel Mahoney as Chief Brand Officer.
Noom Introduces Industry-First $149 Compounded GLP-1 with a Taper-Off Guarantee, Offering a Sustainable Approach to Long-Term Weight Loss
September 12, 2024 08:03 ET
|
Noom Inc
Noom will offer compounded GLP-1 injections paired with Noom’s powerful GLP-1 companion program, providing a sustainable pathway off the medications.
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
August 28, 2024 07:30 ET
|
23andMe, Inc.
SUNNYVALE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lemonaid Health, Inc., a subsidiary of 23andMe Holding Co., (Nasdaq: ME), and a leading telemedicine provider, is now offering Ozempic®, Wegovy®...
Sesame, America’s Low-Cost Leader in Healthcare, Makes Compounded Semaglutide Available to Eligible Patients “At Cost,” with no Retail Price Markup
August 21, 2024 09:00 ET
|
Sesame
NEW YORK CITY, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Sesame, the company that offers Americans quality, convenient health care at half the typical price, today announced the launch of “Success by...
Defiance Launches LLYX, the First 2X Leveraged Single-Stock ETF on Eli Lilly
August 08, 2024 05:00 ET
|
Defiance ETFs
Defiance Launches LLYX, the First 2X Leveraged Single-Stock ETF on Eli Lilly
Original Founders of Akkermansia Muciniphila Bring First Gut Health Product to U.S. Consumer Market
June 27, 2024 11:11 ET
|
The Akkermansia Company
The Akkermansia Company, founded by the first scientists to discover and decode Akkermansia muciniphila, announces its launch into the U.S. consumer market
Noom Introduces AI-Enabled Products to Enhance On-Demand Health Care and Interactive Coaching
June 27, 2024 08:04 ET
|
Noom Inc
Noom launches two state-of-the-art AI-powered features, AI food logging and Welli, Noom’s new AI personal health assistant.
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
June 24, 2024 07:00 ET
|
Rani Therapeutics, LLC
~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery mechanism...
High Use of Ozempic and Other Diabetes Drugs for Weight Loss Driving Down Clothing Sizes In New York City, According to New Study
June 17, 2024 07:00 ET
|
Impact Analytics
Impact Analytics announced that size small has become the most popular size for women on Manhattan’s Upper East Side.
Noom Announces Strategic Expansion of Executive Team with Key Leadership Appointments
June 13, 2024 12:14 ET
|
Noom Inc
Noom, the leading digital healthcare company, announces the appointment of three distinguished executives to its leadership team.